BioregulatorModerate Evidence✦ Khavinson Bioregulator

Thymogen

Also known as: Thymus dipeptide

Khavinson thymus dipeptide bioregulator for immune system regulation.

Evidence

Moderate

FDA status

Not FDA-approved

Source

Synthetic dipeptide thymus bioregulator

Overview

Khavinson thymus dipeptide bioregulator for immune system regulation.

Mechanism of Action

Dipeptide bioregulator for thymus and immune cells, regulates T-cell differentiation and function, modulates cytokine production, enhances cellular and humoral immunity.

What research has looked at

Effects reported in studies, not proven benefits. See the evidence section below for how strong the research is.

  • Immune function
  • T-cell function enhancement
  • Cytokine regulation
  • Reduces immunosenescence
  • Anti-inflammatory when needed

Researched for

Research topics, not approved uses.

ImmunodeficiencyChronic infectionsAge-related immune declineAutoimmune conditions (balancing)Recurrent infections

How Gabriel approaches peptides

Through Gabriel, licensed clinicians may prescribe BPC-157, TB-500, MOTS-c, epitalon and semax (nasal) as compounded medications from licensed 503A pharmacies, under HHS's October 28, 2026 interim policy, and only when appropriate. They are not FDA-approved, and Gabriel never gives peptide dosing. Thymogen isn't prescribed through Gabriel. If you're thinking about it, Gabriel can help you find a licensed clinician to look at the cause of what you're dealing with and the options with stronger evidence.

Read the peptide therapy guide

Research & Evidence

Evidence Level
Moderate
Studies

Russian clinical trials, approved pharmaceutical

Summary

Approved in Russia for immune conditions. Most studies come from Russian groups and have not been confirmed by independent trials elsewhere.

Safety Information

Potential Side Effects

  • •Few side effects reported (limited data)

Contraindications

  • Pregnancy
  • Breastfeeding

Interactions

  • ⚠May enhance other immunotherapies

Quick Facts

CategoryBioregulator
SourceSynthetic dipeptide thymus bioregulator
StatusApproved pharmaceutical in Russia; research compound elsewhere